Answer
The safety and efficacy of avalglucosidase alfa have not yet been established in children aged six months or younger, and no data are available for this age group.
Sources for this answer
- Nexviadyme 100 mg powder for concentrate for solution for infusionSANOFI · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked